In 2022, the lifting of the A-share ban is still lively, and the lifting of the ban continues to exceed 5 trillion yuan throughout the year. As for the current January, the market value of the lifting of the ban reached 449 billion yuan, of which the cro leader Pharmaron Beijing Co.Ltd(300759) whose share price has nearly halved recently faces the lifting of the ban of nearly 70 billion yuan, the most in the month.
the ban will be lifted by 5.11 trillion yuan in 2022
Following the new record of lifting the ban in 2021, the lifting of the ban on A-Shares continued to be high in 2022. According to the data of East Money Information Co.Ltd(300059) choice, 341.637 billion restricted shares are facing lifting in 2022. According to the latest closing price, it is about 5.11 trillion yuan, the third highest in history after 2021 and 2010.
From a monthly perspective, the market value of 449 billion yuan will be lifted in January. The market value of 649.1 billion yuan will be lifted in December 2022, the highest month in 2022.
the main board of Shanghai Stock Exchange is under great pressure
Looking at this month in detail, 234 A-share companies are facing the lifting of the ban, with a total market value of 447.159 billion yuan, involving 8.6631 million shareholders.
In terms of sectors, the main board of Shanghai stock market faces the greatest pressure to lift the ban, with a total market value of 129.3 billion yuan. The pressure of lifting the ban on the science and innovation board is the smallest, with a market value of 46.1 billion yuan facing lifting the ban.
From the perspective of the number of lifting the ban, the main board of Shanghai stock market is also the largest. 65 stocks are facing lifting the ban this month. The second is the gem, with 58 shares facing the lifting of the ban.
As for the recent opening of the Beijing stock exchange, 22 shares faced lifting the ban in January, with a total lifting market value of 79.9 billion yuan.
the ban on power equipment can be lifted up to
From the perspective of the industry, the power equipment industry is facing the greatest pressure to lift the ban this month, with a market value of 99.601 billion yuan. The second is pharmaceutical biology, with a market value of 98.248 billion yuan facing the lifting of the ban. In addition, the lifted market value of transportation, commerce and retail, non bank finance and other industries is also higher.
8 the company lifted the ban, with a market value of more than 10 billion
Looking specifically at the company, among the stocks to be lifted this month, 54 have a market value of more than 1 billion, 16 have a market value of more than 5 billion, and 8 companies have a market value of more than 10 billion yuan.
The Pharmaron Beijing Co.Ltd(300759) lifted on January 28 is the company with the highest market value this month, and all of them are initial shares, with a market value of 69.867 billion yuan. The stock has recently made a significant correction due to the collective weakness of the cro sector. Today, it just brushed back a new low of 129.2 yuan, which is almost halved compared with the historical highest price of 244.6 yuan set in the session on August 5, 2021, and the maximum retreat of 47.2% in about five months.
20 shares lifted, accounting for more than 50% of the total share capital
From the perspective of the proportion of the number of shares lifted to the total share capital, among the individual shares to be lifted this month, the number of shares lifted by 55 companies accounted for more than 20% of the total share capital, and 20 companies accounted for more than 50%. The highest proportion is senxuan medicine, up to 80.92%. New Hope Dairy Co.Ltd(002946) followed, with the lifting of the ban accounting for 80.07% of the total share capital.
Of course, from the correlation between individual stock lifting and stock price in the past, large lifting does not necessarily mean that the stock price falls, and sometimes the stock price rises sharply after lifting the ban. In other words, lifting the ban does not mean that they will be sold. Even if they are sold, they may be frantically robbed in the secondary market. But for investors, these large or large proportion of individual stocks lifted will more or less form a certain “blood drawing effect” at the psychological level, which is the most important.
